title: [Controlateral prophylactic mastectomy: on which arguments?].
authors.affiliation: Département de gynécologie, hôpital Bretonneau, centre hospitalier régional universitaire de Tours, Tours, France. l.ouldamer@chu-tours.fr
authors.forename: L
authors.initials: L
authors.lastname: Ouldamer
authors.forename: A
authors.initials: A
authors.lastname: Trefoux-Bourdet
authors.forename: A
authors.initials: A
authors.lastname: Lebris
authors.forename: G
authors.initials: G
authors.lastname: Body
mesh_terms: D024682:BRCA2 Protein / Q000235:genetics; D001943:Breast Neoplasms / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control*; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D008408:Mastectomy / Q000706:statistics & numerical data; D009154:Mutation; D011379:Prognosis; D012307:Risk Factors; D044767:Ubiquitin-Protein Ligases / Q000235:genetics
chemical_list: D024682:BRCA2 Protein; C551750:BRCA2 protein, human; C111164:BRAP protein, human; D044767:Ubiquitin-Protein Ligases
keywords: Cancer du sein; Chirurgie prophylactique; Mastectomie